文献速递神经肌肉病

转甲状腺素蛋白家族性淀粉样多神经病皮肤神经生物标志物研究

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
PubMed 文献 · Ann Neurol · 2017-06-20

该研究纳入TTR-FAP患者20例、TTR突变携带者10例、健康对照20例、糖尿病神经病对照20例及AL淀粉样变患者2例,通过3mm皮肤活检评估表皮内、汗腺及立毛肌神经纤维密度。结果显示TTR-FAP患者三种神经纤维密度均显著降低,淀粉样负荷与神经纤维密度及NIS-LL评分相关,皮肤淀粉样检测灵敏度70%、特异度100%。

要点

  • 皮肤活检可检测TTR-FAP淀粉样沉积,灵敏度70%、特异度100%。
  • TTR-FAP患者IENFD、SGNFD、PMNFD显著降低,TTR-noPN者呈中间水平。
  • 淀粉样负荷与IENFD、SGNFD、PMNFD及NIS-LL评分相关。

核心结论

  • 皮肤可检测淀粉样沉积,淀粉样负荷与神经纤维密度降低及NIS-LL相关,有望作为TTR-FAP药物试验的生物标志物。

研究设计与样本

  • 研究纳入TTR-FAP患者20例、TTR突变无周围神经病携带者10例、健康对照20例、糖尿病神经病对照20例及AL淀粉样变患者2例,均行神经科检查及3mm皮肤活检。

主要发现

  • TTR-FAP患者IENFD、SGNFD、PMNFD较健康对照显著降低,TTR-noPN者呈中间水平降低。
  • 神经纤维密度降低与NIS-LL评分相关(p < 0.001)。
  • 皮肤淀粉样检测诊断灵敏度70%、特异度100%,AL淀粉样变及2/10例TTR-noPN者刚果红阳性。
  • 淀粉样负荷与IENFD(r = -0.63)、SGNFD(r = -0.67)、PMNFD(r = -0.50)及NIS-LL(r = -0.57)相关。
  • TTR-FAP患者野生型TTR染色较弱。

关键数值与推荐

  • 皮肤淀粉样检测诊断灵敏度70%、特异度100%。
  • 淀粉样负荷与IENFD相关系数r = -0.63,与SGNFD r = -0.67,与PMNFD r = -0.50,与NIS-LL r = -0.57。
  • 神经纤维密度降低与NIS-LL相关p < 0.001。

临床怎么用

  • 皮肤活检可用于TTR-FAP淀粉样诊断,淀粉样负荷可能作为药物试验疗效指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the utility of skin biopsies as a biomarker of disease severity in subjects with amyloid neuropathy. METHODS: Five groups of patients were studied: (1) transthyretin (TTR) familial amyloidotic polyneuropathy (FAP; n = 20), (2) TTR mutation carriers without peripheral neuropathy (TTR-noPN; n = 10), (3) healthy controls (n = 20), (4) diabetic neuropathy disease controls (n = 20), and (5) patients with light-chain (AL) amyloid (n = 2). All subjects underwent neurological examination and 3mm skin biopsies. Sections were stained with anti-PGP9.5, anti-TTR, and Congo red. Intraepidermal (IENFD), sweat gland (SGNFD), and pilomotor nerve fiber densities (PMNFD) were measured. Correlations between the amount of amyloid present (amyloid burden), fiber subtype, and Neuropathy Impairment Score in the Lower Limbs (NIS-LL) were evaluated. RESULTS: IENFD, SGNFD, and PMNFD were all significantly reduced in TTR-FAP patients versus healthy controls, whereas TTR-noPN subjects had intermediate reductions. Lower nerve fiber densities were associated with NIS-LL (p < 0.001). Congo red staining revealed brilliant red amyloid deposits confirmed by apple-green birefringence within dermal collagen, sweat glands, and arrector pili that engulfed axons. The diagnostic sensitivity and specificity to detect amyloid in skin were 70% and 100%. Both AL amyloidosis and 2 of 10 TTR-noPN subjects were Congo red-positive. Amyloid burden correlated with IENFD (r = -0.63), SGNFD (r = -0.67), PMNFD (r = -0.50), and NIS-LL (r = -0.57). Wild-type TTR staining was less prominent in TTR-FAP patients. INTERPRETATION: Cutaneous amyloid was detected in 70% of TTR-FAP and 20% of TTR-noPN subjects. Amyloid burden correlated strongly with reductions in IENFD, SGNFD, PMNFD, and NIS-LL. Skin is an attractive tissue to establish an amyloid diagnosis, and amyloid burden has potential as a biomarker to detect treatment effect in TTR-FAP drug trials. Ann Neurol 2017;82:44-56.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Ebenezer GJ, Liu Y, Judge DP, et al. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. Ann Neurol. 2017. PMID: 28598015. doi:10.1002/ana.24972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。